Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Mulvihill Canadian Bank Enhanced Yield ETF
T.CBNK
Mulvihill Canadian Bank Enhanced Yield ETF is an exchange traded fund launched and managed by Strathbridge Asset Management Inc. The fund invests in public equity markets of Canada. The fund invests directly and through derivatives in stocks of companies operating across financials, banks sectors. It uses derivatives such as options to create its portfolio. It invests in growth and value stocks...
of companies across diversified market capitalization. Mulvihill Canadian Bank Enhanced Yield ETF was formed on February 25, 2022 and is domiciled in Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSX:CBNK)
New Post
View:
Posts & Comments
Threaded Posts
(8)
•••
swpb
X
Comment by
swpb
on Sep 10, 2025 1:14am
RE:RE:Calling all income seekers
Cbnk trades very sparcely. Does anyone know how the distributions are handled tax wise? Are the distributions treated like a capital gains? Is there a dividend tax credit for the distributions?
(45)
•••
ANALOG GUY
X
Comment by
ANALOG GUY
on Jan 26, 2023 1:25pm
RE:Calling all income seekers
Now owning 20,000 shares at $7.80 average 9% yield going to own these forever if you want a "sleep at night " ETF with monthly income and tax efficiency this should be
...more
DiagnosTear Announces Clinical Study with AlyaTec
posted Dec 04, 2025 9:00am by
Diagnostear Technologies Inc
-
|
TeaRx™ Red Eye is being developed as the first rapid, multi-biomarker diagnostic test designed to differentiate between Adenoviral conjunctivitis, Herpetic keratitis, and Allergic conjunctivitis at the point of care. These three conditions drive hundreds of millions of clinic visits every year, yet misdiagnosis remains widespread due to the absence of fast, accurate testing. TeaRx™ aims to change that with a simple test that delivers clinical answers in minutes. ...read more
(45)
•••
ANALOG GUY
X
Post by
ANALOG GUY
on Dec 13, 2022 5:23pm
Calling all income seekers
ETF holds big 6 Canadian banks covered call with 25% leverage 9% dividend plus the dividend tax credit for tax efficiency :)
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)
A Company Focused on Developing Functional Healthier “Better For You” Foods
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland
Building Momentum in One of the World's Most Prospective Copper Regions